Edward Cliff, Clinical Research Fellow at WEHI, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Hot off the press in Nature Portfolio Reviews Clinical Oncology: in the wake of MajesTEC-9, presented at ASCO, we ask the provocative question, does cilta-cel have a future in myeloma?”
Title: Does ciltacabtagene autoleucel have a future in multiple myeloma?
Authors: Ghulam Rehman Mohyuddin, Edward R. Scheffer Cliff, Rajshekhar Chakraborty
Read the Full Article on Nature Reviews Clinical Oncology
More posts featuring Edward Cliff.
